| Literature DB >> 20650679 |
Mary P Fairchok1, Emily T Martin, Susan Chambers, Jane Kuypers, Melinda Behrens, Loranee E Braun, Janet A Englund.
Abstract
BACKGROUND: The epidemiology of respiratory tract infections (RTIs) in a daycare cohort has not been explored using molecular techniques.Entities:
Mesh:
Year: 2010 PMID: 20650679 PMCID: PMC7108368 DOI: 10.1016/j.jcv.2010.06.013
Source DB: PubMed Journal: J Clin Virol ISSN: 1386-6532 Impact factor: 3.168
Age at enrollment as a risk factor for infection in the most commonly identified viruses.
| 0–6 months at enrollment | >6–12 months at enrollment | 12–24 months at enrollment | |||
|---|---|---|---|---|---|
| Incidence/child year (95%C.I.) | Incidence/child year (95%C.I.) | Hazard ratio | Incidence/child year (95%C.I.) | Hazard ratio; | |
| All RTIs (318) | 3.5 (2.8, 4.3) | 3.5 (2.7, 4.4) | 1.00; | 1.8 (1.4, 2.3) | 0.57; |
| RhV (111) | 1.3 (0.9, 1.8) | 1.3 (1.0, 1.8) | 1.02; | 0.5 (0.3, 1.0) | 0.43; |
| AdV (69) | 0.9 (.0.6, 1.6) | 0.8 (4.6, 1.3) | 0.83; | 2.5 (0.1, 0.5) | 0.30; |
| CoV (48) | 0.6 (0.4, 1.0) | 0.5 (0.3, 1.1) | 0.90; | 0.2 (0.1, 0.5) | 0.40; |
| PIV (37) | 0.3 (0.2, 0.6) | 0.6 (0.3, 1.0) | 1.80; | 0.2 (0.1, 0.4) | 0.61; |
| RSV (35) | 0.5 (0.3, 0.8) | 0.3 (0.2, 0.6) | 0.76; | 0.2 (0.09, 0.3) | 0.46; |
| MPV (14) | 0.2 (0.05, 0.8) | 0.2 (0.07, 0.4) | 1.02; | 0.06 (0.02, 0.3) | 0.46; |
RTIs, respiratory tract infections; RhV, rhinovirus; AdV, adenovirus; CoV, human coronavirus; PIV, parainfluenza viruses; RSV, respiratory syncytial virus; MPV, human metapneumovirus.
Hazard ratios are calculated in comparison to the 0–6 months age group.
Fig. 1Viral identification.
Characteristics of 318 respiratory tract infections.
| Characteristic | Single | Coinf | None | RhV | Adv | CoV | PIV | RSV | Flu A | HMPV |
|---|---|---|---|---|---|---|---|---|---|---|
| Total (%) RTIs | 126 (40) | 87 (27) | 105 (33) | 111 (35) | 69 (22) | 48 (15) | 37 (12) | 35 (11) | 7 (2) | 14 (4) |
| Mean age (months) | 13.2 | 11.5 | 12.3 | 12.4 | 10.4 | 11.8 | 13.1 | 12.4 | 17.9 | 12.0 |
| 65 (52) | 50 (57) | 56 (53) | 69 (62) | 40 (58) | 29 (60) | 14 (38) | 17 (49) | 2 (29) | 8 (57) | |
| Single infections only | ||||||||||
| Number (%) RTIs as single virus identified | 126 (100) | N/A | N/A | 50 (16) | 17 (5) | 14 (4) | 14 (4) | 20 (6) | 5 (2) | 5 (2) |
| Mean (range) of peak viral load (log copies/mL) | N/A | 5.0 (2.9, 7.9) | 6.5 (4.5, 9.2) | 6.2 (3.5, 8.5) | 7.9 (5.4, 9.4) | 7.1 (6.1, 8.1) | 6.9 (5.5, 9.4) | |||
| Mean duration (days) | 8.2 | 8.7 | 7.4 | 8.2 | 9.1 | 7.9 | 8.4 | 8.6 | 7.8 | 6.2 |
| | 67 (53) | 39 (46) | 44 (42) | 25 (50) | 8 (47) | 4 (29) | 6 (43) | 16 (80) | 5 (100) | 3 (60) |
| | 43 (34) | 34 (39) | 34 (32) | 17 (34) | 6 (35) | 3 (21) | 4 (29) | 10 (50) | 0 (0) | 3 (60) |
| Mean days DC missed | 1.1 | 1.2 | 1.1 | 0.7 | 1.1 | 1.7 | 0.9 | 1.4 | 3 | 1 |
| Mean days work missed | 0.9 | 1.2 | 1.1 | 0.7 | 0.7 | 0.9 | 0.9 | 1.4 | 2.8 | 1 |
| | 62 (49) | 44 (51) | 41 (39) | 18 (36) | 8 (47) | 5 (36) | 9 (64) | 16 (80) | 2 (40) | 3 (60) |
| Co-infections only | ||||||||||
| Number (%) of RTIs with virus as co-infection | 61 (19) | 52 (16) | 34 (11) | 23 (7) | 15 (5) | 2 (0.6) | 9 (0.3) | |||
| Mean (range) of peak viral load, log copies/mL | N/A | 4.6 (2.5, 7.6) | 6.7 (2.8, 10.1) | 6.2 (2.5, 9.8) | 7.3 (3.7, 9.0) | 6.1 (3.6, 8.6) | 6.3 (4.0, 8.4) | |||
| Mean duration (days) | 8.6 | 8.6 | 8.8 | 8.3 | 9.1 | 9 | 9.3 | |||
| | 29 (48) | 22 (44) | 14 (41) | 10 (43) | 8 (53) | 1 (50) | 4 (44) | |||
| | 22 (36) | 19 (37) | 14 (41) | 8 (35) | 10 (67) | 1 (50) | 4 (44) | |||
| Mean days DC missed | 1.2 | 1.2 | 1.2 | 1.3 | 1.8 | 0.5 | 1.8 | |||
| Mean days work missed | 1.2 | 1.1 | 1.1 | 1.3 | 1.9 | 0.5 | 1.1 | |||
| | 30 (49) | 23 (44) | 16 (47) | 16 (70) | 10 (67) | 0 (0) | 5 (56) | |||
RhV, rhinovirus; AdV, adenovirus; CoV, human coronavirus; PIV, parainfluenza viruses; RSV, respiratory syncytial virus; flu A, influenza virus A; MPV, human metapneumovirus; RTIs, respiratory tract infections.
p = 0.001.
p = 0.002.
p = 0.02.
p = 0.01.
p = 0.007.
p = 0.009.
Fig. 2Seasonal pattern of individual viral detection consolidated over 2 years.
Case crossover analysis of asymptomatic viral detection compared to the first subsequent illness in the same subject.
| Virus | Virus-specific prevalence at asymptomatic enrollment, | Virus-specific prevalence at first study illness, | |
|---|---|---|---|
| RhV | 5 (20) | 11 (44) | 0.06 |
| AdV | 5 (20) | 6 (24) | 0.71 |
| CoV | 1 (4) | 3 (12) | 0.32 |
| PIV (types 1–4) | 1 (4) | 5 (20) | 0.046 |
| RSV | 0 (0) | 4 (16) | 0.046 |
| Flu A | 1 (4) | 0 (0) | 0.32 |
| HMPV | 0 (0) | 0 (0) | n.s. |
| Any positive | 11 (44) | 19 (76) | 0.02 |
RhV, rhinovirus; AdV, adenovirus; CoV, human coronavirus; PIV, parainfluenza viruses; RSV, respiratory syncytial virus; flu A, influenza virus A; HMPV, human metapneumovirus.
p value is for matched comparisons of prevalence using McNemar's test.